Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-25 @ 3:20 AM
NCT ID:
NCT00786305
Eligibility Criteria:
Inclusion Criteria:
* Male or female \>18 years old, ventilator associated pneumonia caused by pseudomonas aeruginosa
* Written informed consent provided by the relatives
Exclusion Criteria:
* Pseudomonas aeruginosa resistant to ceftazidime and amikacin
* Pseudomonas aeruginosa pneumonia associated with other infections requiring intravenous treatment
* Severe septic shock and severe hypoxemia
* Allergy to ceftazidime or amikacin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00786305
Study Brief:
Protocol Section:
NCT00786305